10-Q Filing

NEOGENOMICS INC CIK: 1077183 Q2 2018

Filing Information

Form Type	10-Q
Accession Number	`0001077183-18-000075`
Period End Date	20180630
Filing Date	20180806
Fiscal Year	2018
Fiscal Period	Q2
XBRL Instance	neo-20180630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 92 Cash Flow Statement 66 Comprehensive Income 20

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$40.53M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$45.68M	USD	Point-in-time
Redeemable Convertible Preferred Stock, par value (in dollars per share)	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Redeemable Convertible Preferred Stock, par value (in dollars per share)	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.44M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.82M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares authorized	`TemporaryEquitySharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.53M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.93M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares authorized	`TemporaryEquitySharesAuthorized`	50.00M	shares	Point-in-time
Redeemable Convertible Preferred Stock, shares issued	`TemporaryEquitySharesIssued`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$60.77M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares issued	`TemporaryEquitySharesIssued`	6.86M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$60.43M	USD	Point-in-time
Inventories	`InventoryNet`	$7.47M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares outstanding	`TemporaryEquitySharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$6.90M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares outstanding	`TemporaryEquitySharesOutstanding`	6.86M	shares	Point-in-time
Other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.15M	USD	Point-in-time
Other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.16M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$85.88M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$83.26M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Property and equipment (net of accumulated depreciation of $45,678 and $40,530, respectively)	`PropertyPlantAndEquipmentNet`	$36.50M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	80.46M	shares	Point-in-time
Property and equipment (net of accumulated depreciation of $45,678 and $40,530, respectively)	`PropertyPlantAndEquipmentNet`	$42.87M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	81.63M	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$71.33M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	81.63M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	80.46M	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$74.17M	USD	Point-in-time
Goodwill	`Goodwill`	$147.02M	USD	Point-in-time
Goodwill	`Goodwill`	$147.02M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.30M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$891.00K	USD	Point-in-time
Total assets	`Assets`	$344.45M	USD	Point-in-time
Total assets	`Assets`	$345.78M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$12.34M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.45M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$9.48M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$11.18M	USD	Point-in-time
Accrued expenses and other liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$9.89M	USD	Point-in-time
Accrued expenses and other liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$6.14M	USD	Point-in-time
Short-term portion of capital leases and car loans	`CapitalLeaseObligationsandAutoLoansCurrent`	$5.24M	USD	Point-in-time
Short-term portion of capital leases and car loans	`CapitalLeaseObligationsandAutoLoansCurrent`	$5.85M	USD	Point-in-time
Short-term portion of loans	`SecuredDebtCurrent`	$3.75M	USD	Point-in-time
Short-term portion of loans	`SecuredDebtCurrent`	$6.56M	USD	Point-in-time
Pharma contract liability	`ContractWithCustomerLiabilityCurrent`	$1.41M	USD	Point-in-time
Pharma contract liability	`ContractWithCustomerLiabilityCurrent`	$2.15M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$47.97M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$36.47M	USD	Point-in-time
Long-term portion of capital leases and car loans	`CapitalLeaseObligationsAndAutoLoansNoncurrent`	$5.41M	USD	Point-in-time
Long-term portion of capital leases and car loans	`CapitalLeaseObligationsAndAutoLoansNoncurrent`	$5.30M	USD	Point-in-time
Long-term portion of loans, net	`SecuredLongTermDebt`	$91.53M	USD	Point-in-time
Long-term portion of loans, net	`SecuredLongTermDebt`	$66.62M	USD	Point-in-time
Revolving credit facility, net	`LongTermLineOfCredit`	$29.18M	USD	Point-in-time
Revolving credit facility, net	`LongTermLineOfCredit`	$24.52M	USD	Point-in-time
Long-term pharma contract liability	`ContractWithCustomerLiabilityNoncurrent`	$648.00K	USD	Point-in-time
Long-term pharma contract liability	`ContractWithCustomerLiabilityNoncurrent`	$283.00K	USD	Point-in-time
Deferred income tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$6.83M	USD	Point-in-time
Deferred income tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$6.69M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$133.60M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$103.41M	USD	Point-in-time
Total liabilities	`Liabilities`	$139.88M	USD	Point-in-time
Total liabilities	`Liabilities`	$181.57M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series A Redeemable Convertible Preferred Stock, $0.001 par value, (50,000,000 shares authorized; 0 and 6,864,000 shares issued and outstanding)	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	$32.62M	USD	Point-in-time
Series A Redeemable Convertible Preferred Stock, $0.001 par value, (50,000,000 shares authorized; 0 and 6,864,000 shares issued and outstanding)	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	-	USD	Point-in-time
Common stock, $0.001 par value, (250,000,000 shares authorized; 81,632,045 and 80,462,574 shares issued and outstanding, respectively)	`CommonStockValueOutstanding`	$81.00K	USD	Point-in-time
Common stock, $0.001 par value, (250,000,000 shares authorized; 81,632,045 and 80,462,574 shares issued and outstanding, respectively)	`CommonStockValueOutstanding`	$80.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$230.03M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$217.45M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$274.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$257.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-58.42M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-53.58M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$171.96M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$164.21M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$344.45M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$345.78M	USD	Point-in-time

Income Statement 92 line items

Line Item	Tag	Value	Unit	Period
Clinical Services	`ClinicalTestingRevenue`	$116.51M	USD	2 Qtrs
Clinical Services	`ClinicalTestingRevenue`	$108.45M	USD	2 Qtrs
Clinical Services	`ClinicalTestingRevenue`	$55.55M	USD	1 Quarter
Clinical Services	`ClinicalTestingRevenue`	$59.54M	USD	1 Quarter
Pharma Services	`PharmaServices`	$6.72M	USD	1 Quarter
Pharma Services	`PharmaServices`	$11.24M	USD	2 Qtrs
Pharma Services	`PharmaServices`	$8.21M	USD	1 Quarter
Pharma Services	`PharmaServices`	$14.66M	USD	2 Qtrs
Total Revenue	`SalesRevenueServicesNet`	$131.17M	USD	2 Qtrs
Total Revenue	`SalesRevenueServicesNet`	$67.75M	USD	1 Quarter
Total Revenue	`SalesRevenueServicesNet`	$119.69M	USD	2 Qtrs
Total Revenue	`SalesRevenueServicesNet`	$62.26M	USD	1 Quarter
COST OF REVENUE	`CostOfServices`	$69.39M	USD	2 Qtrs
COST OF REVENUE	`CostOfServices`	$73.34M	USD	2 Qtrs
COST OF REVENUE	`CostOfServices`	$34.91M	USD	1 Quarter
COST OF REVENUE	`CostOfServices`	$37.22M	USD	1 Quarter
GROSS PROFIT	`GrossProfit`	$30.53M	USD	1 Quarter
GROSS PROFIT	`GrossProfit`	$50.30M	USD	2 Qtrs
GROSS PROFIT	`GrossProfit`	$57.83M	USD	2 Qtrs
GROSS PROFIT	`GrossProfit`	$27.35M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$18.43M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$20.98M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$38.05M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$35.45M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$947.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.03M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.07M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.81M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$11.78M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$14.46M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$6.13M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$7.68M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$49.04M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$25.51M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$29.74M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$54.53M	USD	2 Qtrs
Income from Operations	`OperatingIncomeLoss`	$1.26M	USD	2 Qtrs
Income from Operations	`OperatingIncomeLoss`	$794.00K	USD	1 Quarter
Income from Operations	`OperatingIncomeLoss`	$1.84M	USD	1 Quarter
Income from Operations	`OperatingIncomeLoss`	$3.30M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNet`	$-2.89M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNet`	$-2.77M	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNet`	$-1.41M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-1.41M	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	-	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	-	USD	2 Qtrs
Other expense	`OtherNonoperatingExpense`	$124.00K	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$62.00K	USD	2 Qtrs
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$345.00K	USD	2 Qtrs
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.51M	USD	2 Qtrs
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-737.00K	USD	1 Quarter
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$430.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-53.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-832.00K	USD	2 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-357.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$81.00K	USD	2 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$483.00K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$264.00K	USD	2 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$-680.00K	USD	2 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$-380.00K	USD	1 Quarter
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$947.00K	USD	1 Quarter
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$929.00K	USD	1 Quarter
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$1.82M	USD	2 Qtrs
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$1.95M	USD	2 Qtrs
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$3.68M	USD	2 Qtrs
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$1.82M	USD	1 Quarter
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$1.71M	USD	1 Quarter
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$3.38M	USD	2 Qtrs
Gain on redemption of preferred stock	`GainLossOnRedemptionOfPreferredStock`	-	USD	1 Quarter
Gain on redemption of preferred stock	`GainLossOnRedemptionOfPreferredStock`	$9.07M	USD	1 Quarter
Gain on redemption of preferred stock	`GainLossOnRedemptionOfPreferredStock`	-	USD	2 Qtrs
Gain on redemption of preferred stock	`GainLossOnRedemptionOfPreferredStock`	$9.07M	USD	2 Qtrs
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$5.92M	USD	1 Quarter
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$3.71M	USD	2 Qtrs
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.88M	USD	2 Qtrs
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.16M	USD	1 Quarter
Basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.07	USD	2 Qtrs
Basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.07	USD	1 Quarter
Basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.05	USD	2 Qtrs
Basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.03	USD	1 Quarter
Diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.03	USD	1 Quarter
Diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.07	USD	2 Qtrs
Diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.07	USD	1 Quarter
Diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.04	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	81.02M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	80.79M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	79.41M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	79.08M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	79.41M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	90.17M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	89.31M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	79.08M	shares	2 Qtrs

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$483.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$264.00K	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-680.00K	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-380.00K	USD	1 Quarter
Depreciation	`Depreciation`	$7.91M	USD	2 Qtrs
Depreciation	`Depreciation`	$7.44M	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$3.45M	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$2.83M	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.40M	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.70M	USD	1 Quarter
Amortization of debt issue costs	`AmortizationOfFinancingCosts`	$219.00K	USD	2 Qtrs
Amortization of debt issue costs	`AmortizationOfFinancingCosts`	$242.00K	USD	2 Qtrs
Loss on disposal of assets	`GainLossOnSaleOfBusiness`	-	USD	2 Qtrs
Loss on disposal of assets	`GainLossOnSaleOfBusiness`	$-106.00K	USD	2 Qtrs
Non-cash stock based compensation	`ShareBasedCompensation`	$3.96M	USD	2 Qtrs
Non-cash stock based compensation	`ShareBasedCompensation`	$3.05M	USD	2 Qtrs
(Increase) in accounts receivable, net of write-offs	`IncreaseDecreaseInAccountsReceivable`	$338.00K	USD	2 Qtrs
(Increase) in accounts receivable, net of write-offs	`IncreaseDecreaseInAccountsReceivable`	$6.25M	USD	2 Qtrs
Decrease in inventories	`IncreaseDecreaseInInventories`	$-796.00K	USD	2 Qtrs
Decrease in inventories	`IncreaseDecreaseInInventories`	$-576.00K	USD	2 Qtrs
(Increase) in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$720.00K	USD	2 Qtrs
(Increase) in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$2.20M	USD	2 Qtrs
(Increase) in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$977.00K	USD	2 Qtrs
(Increase) in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$129.00K	USD	2 Qtrs
Increase (decrease) in accounts payable, accrued and other liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$-2.80M	USD	2 Qtrs
Increase (decrease) in accounts payable, accrued and other liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$9.04M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.84M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$20.95M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.86M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.94M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.94M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-7.86M	USD	2 Qtrs
Advances from revolving credit facility, net	`ProceedsFromLinesOfCredit`	$10.00M	USD	2 Qtrs
Advances from revolving credit facility, net	`ProceedsFromLinesOfCredit`	$5.00M	USD	2 Qtrs
Redemption of preferred stock	`PaymentsForRepurchaseOfRedeemablePreferredStock`	$50.10M	USD	2 Qtrs
Redemption of preferred stock	`PaymentsForRepurchaseOfRedeemablePreferredStock`	-	USD	2 Qtrs
Repayment of capital lease obligations, loans	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$3.01M	USD	2 Qtrs
Repayment of capital lease obligations, loans	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$2.75M	USD	2 Qtrs
Repayment of term loan and revolving credit facility	`RepaymentsOfLongTermLinesOfCredit`	$7.28M	USD	2 Qtrs
Repayment of term loan and revolving credit facility	`RepaymentsOfLongTermLinesOfCredit`	$1.88M	USD	2 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$5.59M	USD	2 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.18M	USD	2 Qtrs
Proceeds from term loan	`ProceedsFromIssuanceOfSecuredDebt`	$30.00M	USD	2 Qtrs
Proceeds from term loan	`ProceedsFromIssuanceOfSecuredDebt`	-	USD	2 Qtrs
Payments of debt issue costs	`PaymentsOfStockIssuanceCosts`	$112.00K	USD	2 Qtrs
Payments of debt issue costs	`PaymentsOfStockIssuanceCosts`	$576.00K	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.43M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-15.37M	USD	2 Qtrs
Effects of foreign exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	-	USD	2 Qtrs
Effects of foreign exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-22.00K	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.59M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-3.39M	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$9.44M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$12.82M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$12.53M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$10.93M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$9.44M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$12.82M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$12.53M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$10.93M	USD	Point-in-time
Interest paid	`InterestPaid`	$2.57M	USD	2 Qtrs
Interest paid	`InterestPaid`	$2.70M	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$102.00K	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$49.00K	USD	2 Qtrs
Equipment acquired under capital lease/loan obligations	`CapitalLeaseObligationsIncurred`	$2.56M	USD	2 Qtrs
Equipment acquired under capital lease/loan obligations	`CapitalLeaseObligationsIncurred`	$3.73M	USD	2 Qtrs

Comprehensive Income 20 line items

Line Item	Tag	Value	Unit	Period
NET INCOME(LOSS)	`NetIncomeLoss`	$483.00K	USD	1 Quarter
NET INCOME(LOSS)	`NetIncomeLoss`	$264.00K	USD	2 Qtrs
NET INCOME(LOSS)	`NetIncomeLoss`	$-680.00K	USD	2 Qtrs
NET INCOME(LOSS)	`NetIncomeLoss`	$-380.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-22.00K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$6.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	2 Qtrs
Gain (loss) on effective cash flow hedge	`OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent`	$5.00K	USD	2 Qtrs
Gain (loss) on effective cash flow hedge	`OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent`	-	USD	2 Qtrs
Gain (loss) on effective cash flow hedge	`OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Gain (loss) on effective cash flow hedge	`OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent`	$-266.00K	USD	1 Quarter
Total other comprehensive (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Total other comprehensive (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	-	USD	2 Qtrs
Total other comprehensive (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-17.00K	USD	2 Qtrs
Total other comprehensive (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-260.00K	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$247.00K	USD	2 Qtrs
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-640.00K	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$483.00K	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-680.00K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.